NIH Administrative Supplement

An NIH administrative supplement (also called a “Type 3” award in NIH’s own activity-code nomenclature) is a request for additional funds added to an already-active NIH grant or cooperative agreement, to cover either unforeseen cost increases or new, but in-scope, research activities within the parent award’s current competitive segment. It is not a new grant application and it does not go through NIH’s standard scientific peer review — it is evaluated administratively by the funding Institute or Center’s program and grants management staff. Supplement funding cannot extend past the parent award’s approved project period, and it cannot fund work outside the scope NIH’s peer reviewers already approved when the parent grant was funded. This general mechanism is what makes specific named programs — such as the NIH Research Supplements to Promote Diversity in Health-Related Research (“diversity supplement”) — possible: a diversity supplement is one specific, named use case of the broader administrative-supplement mechanism described here, not a separate funding instrument.

What Qualifies as an Administrative Supplement

NIH’s standing parent funding opportunity for this mechanism — “Administrative Supplements to Existing NIH Grants and Cooperative Agreements” — has been reissued periodically under a series of PA numbers as each prior version expires (recent versions include PA-20-272 and PA-26-001; institutions should always confirm the currently active PA number on grants.nih.gov before applying, since NIH parent announcements are typically reissued every few years). Two broad categories of request fall under it:

• Cost increases from unforeseen circumstances. The award’s approved scope of work hasn’t changed, but a circumstance not anticipated at the time of the original competing application — a required regulatory change, an unexpected price increase in a specialized reagent or service, a facility issue — has raised the cost of completing that same, already-approved work.
• New activities within the original scope. The request adds a research activity, additional personnel, or an expansion of the project that a reasonable reviewer would recognize as a natural extension of the aims NIH’s peer reviewers already evaluated and approved — not a new scientific direction. NIH’s own guidance frames this as work that “would increase or preserve the overall impact” of the project as originally reviewed.

Beyond the general parent announcement, individual NIH Institutes and Centers periodically issue targeted Notices of Special Interest (NOSIs) that use the administrative-supplement mechanism to fund a specific initiative — for example, adding a trainee from an underrepresented background (the diversity-supplement program), supporting a collaboration to improve a dataset’s AI/ML readiness, or responding to a public-health emergency within the scope of an already-funded project. These NOSIs don’t create a different review process; they layer additional, initiative-specific eligibility and application instructions on top of the same non-competing administrative-review mechanism.

How It Differs From a Competing Renewal

Research administrators new to the mechanism sometimes conflate an administrative supplement with a competing renewal (a Type 2 application) because both add money to ongoing work by the same investigator. They are structurally different:

• Review. A competing renewal is a new application that goes through NIH’s standard scientific peer review (a study section evaluates it against other applications). An administrative supplement is reviewed administratively by program/grants management staff at the Institute or Center — there is no study section, no priority score, and no competition against other applicants.
• Timing and scope of funds. A competing renewal funds a new competitive segment, potentially with a substantially revised scope, budget, and project period, starting after the current segment ends. A supplement adds funds within the current, already-approved competitive segment and project period — it cannot extend the award past its existing end date.
• Who can request one. Only the principal investigator/program director of an award that is currently active can request a supplement. There is no such thing as a supplement to a lapsed, closed, or not-yet-awarded grant, and a supplement cannot itself add or remove a PI on the parent award.
• Scope change allowed. A competing renewal can propose meaningfully new science. A supplement is explicitly bounded to work within, or a natural incremental extension of, the scope NIH already reviewed — genuinely new scientific aims belong in a new competing application, not a supplement request.

Who Requests One, and How

The parent award’s PI or PD (not the institution’s sponsored-programs office alone, and not a proposed new investigator) initiates the request, typically by working with their Institute/Center program officer before submitting a formal supplement request through the institution’s signing official. Because there is no competitive peer review, timelines are generally shorter than a new application, but they still run through NIH’s grants management process and are subject to that fiscal year’s available funds — a supplement request is not guaranteed funding simply because it is administratively reviewed rather than peer-reviewed.

Worked Examples

• A PI on an active R01 requests a one-year administrative supplement under the diversity-supplement parent announcement to add a postdoctoral researcher from a group underrepresented in health-related research to the existing project team, funding that trainee’s stipend and directly related research costs through the parent award’s remaining project period. See NIH Diversity Supplement: Eligibility and How to Apply for the full mechanics of this specific named use of the general mechanism.
• A lab with an active, multi-year R01 studying an emerging infectious disease receives an administrative supplement under an Institute-specific NOSI to purchase equipment and run additional assays needed to respond to a public-health development directly relevant to the project’s already-approved aims — without submitting a new competing application or waiting for the next renewal cycle.
• A cooperative agreement’s data-collection costs rise unexpectedly because a required protocol modification increases per-participant procedure costs; the PI requests a supplement to cover the increase and preserve the study’s originally approved scope and sample size, rather than cutting enrollment to stay within the original budget.

Counter-Example

A PI on an active R01 wants to pursue an entirely new hypothesis that emerged from preliminary data, unrelated to the funded project’s approved specific aims. Because this is new science rather than an incremental extension of already-reviewed work, it is not eligible for an administrative supplement — the PI needs a new competing application (a new R01, or a competing renewal at the appropriate cycle) that goes through standard peer review. Likewise, a researcher who does not currently hold any active NIH award has no parent grant to attach a supplement request to; the mechanism cannot be used to obtain first-time NIH funding.

Related Terms

Distinct from the OMB Compliance Supplement, which is an unrelated annual audit-guidance document under 2 CFR Part 200 — the shared word “supplement” is a naming coincidence, not a conceptual overlap. See also the NIH Grants Policy Statement, which governs administrative-supplement terms and conditions as part of NIH’s broader award terms; the Cooperative Agreement mechanism, which (alongside grants) can also receive administrative supplements; and the Funding Opportunity Announcement (FOA) term for how NIH’s parent announcements fit into the broader funding-opportunity taxonomy.